BRIEF-OSE Immunotherapeutics to present preclinical data of its new checkpoint inhibitor

Oct 4 OSE Immunotherapeutics SA :

* To present the preclinical data of its new checkpoint
inhibitor EFFI-dem on SIRP-/cd47 strategic pathway at the 2016
immune checkpoint inhibitors conference
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)